NEW YORK, Dec. 17 – Swedish microfluidics company Gyros has raised 309 million krona, $29.5 million, in a second round of private financing. 

The investors included 3i, the Swedish Industrial Development Fund, InnovationsKapital, and H&B Capital. In addition, existing investors such as Investor AB, the National Pension Insurance Fund, Karolinska Investment Fund, HealthCap, and the Swedish Union of Clerical and Technical Employees in Industry, have increased their contributions. 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

With H3Africa, Charles Rotimi has been working to bolster the representation of African participants and African researchers in genomics, Newsweek reports.

NPR reports that government and private insurers are being slow to cover recently approved CAR-T cell therapies.

CNBC reports that there are thousands of genetic tests available for consumers to chose between.

In Nature this week: genomic analysis of ducks, whole-genome doubling among tumor samples, and more.